Your browser doesn't support javascript.
loading
Cancer tissue of origin constrains the growth and metabolism of metastases.
Sivanand, Sharanya; Gultekin, Yetis; Winter, Peter S; Vermeulen, Sidney Y; Tchourine, Konstantine M; Abbott, Keene L; Danai, Laura V; Gourgue, Florian; Do, Brian T; Crowder, Kayla; Kunchok, Tenzin; Lau, Allison N; Darnell, Alicia M; Jefferson, Alexandria; Morita, Satoru; Duda, Dan G; Aguirre, Andrew J; Wolpin, Brian M; Henning, Nicole; Spanoudaki, Virginia; Maiorino, Laura; Irvine, Darrell J; Yilmaz, Omer H; Lewis, Caroline A; Vitkup, Dennis; Shalek, Alex K; Vander Heiden, Matthew G.
Afiliação
  • Sivanand S; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Gultekin Y; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Winter PS; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Vermeulen SY; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Tchourine KM; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Abbott KL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Danai LV; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Gourgue F; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Do BT; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Crowder K; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Kunchok T; Department of Systems Biology, Columbia University Medical Center, New York, NY, USA.
  • Lau AN; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Darnell AM; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Jefferson A; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Morita S; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Duda DG; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Aguirre AJ; Department of Biochemistry and Molecular Biology, University of Massachusetts Amherst, Amherst, MA, USA.
  • Wolpin BM; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Henning N; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Spanoudaki V; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Maiorino L; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Irvine DJ; Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
  • Yilmaz OH; Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
  • Lewis CA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Vitkup D; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Shalek AK; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Vander Heiden MG; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
Nat Metab ; 6(9): 1668-1681, 2024 Sep.
Article em En | MEDLINE | ID: mdl-39160333
ABSTRACT
Metastases arise from subsets of cancer cells that disseminate from the primary tumour1,2. The ability of cancer cells to thrive in a new tissue site is influenced by genetic and epigenetic changes that are important for disease initiation and progression, but these factors alone do not predict if and where cancers metastasize3,4. Specific cancer types metastasize to consistent subsets of tissues, suggesting that primary tumour-associated factors influence where cancers can grow. We find primary and metastatic pancreatic tumours have metabolic similarities and that the tumour-initiating capacity and proliferation of both primary-derived and metastasis-derived cells is favoured in the primary site relative to the metastatic site. Moreover, propagating cells as tumours in the lung or the liver does not enhance their relative ability to form large tumours in those sites, change their preference to grow in the primary site, nor stably alter aspects of their metabolism relative to primary tumours. Primary liver and lung cancer cells also exhibit a preference to grow in their primary site relative to metastatic sites. These data suggest cancer tissue of origin influences both primary and metastatic tumour metabolism and may impact where cancer cells can metastasize.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proliferação de Células / Metástase Neoplásica Limite: Animals / Humans Idioma: En Revista: Nat Metab Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proliferação de Células / Metástase Neoplásica Limite: Animals / Humans Idioma: En Revista: Nat Metab Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos